Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for self-control resource depletion in healthy adults
ACTRN12611000564954Phase 4Not yet recruiting
- Sponsor
- University of Melbourne
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate (2 arms), sponsored by University of Melbourne. Primary endpoint: Resource depletion cognitive performance. Planned start Jul 2011; status: not yet recruiting.
02
Drugs
methylphenidate
Beyond the preview
Go deeper on ACTRN12611000564954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000564954.